Botulism immune globulin
Alternative Names: BabyBIG; BIG-IV; Botulinum toxin immune globulin; Botulism immune globulin intravenous (human); Botulism IVIG; Human-derived botulinum antitoxin; IV botulism immune globulinLatest Information Update: 10 Mar 2004
At a glance
- Originator California Department of Health Services
- Class Immunoglobulins
- Mechanism of Action Botulinum toxin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Botulism
Most Recent Events
- 31 Dec 2003 Launched for Botulism in USA (IV)
- 23 Oct 2003 Registered for Botulism in USA (IV)